Accession Number: | 0001179110-20-007719 |
Date: | 2020-06-19 |
Issuer: | BLUEPRINT MEDICINES CORP (BPMC) |
Original Submission Date: |
ROWLAND CHARLES A JR
C/O BLUEPRINT MEDICINES CORPORATION
45 SIDNEY STREET
CAMBRIDGE, MA 02139
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2020-06-19 | M | 1,312 | a | $0.00 | 1,312 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
RESTRICTED STOCK UNITS | 0.0 | 2020-06-19 | deemed execution date | M | 1,312 (d) | common stock 1,312 | $0.00 | 0 | direct |
ID | footnote |
---|---|
f1 | each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. |
f2 | on june 19, 2019, the reporting person was granted 1,312 restricted stock units. these restricted stock units are fully vested. |